PHG vs HUM vs GEHC Stock Comparison

Koninklijke Philips, Humana and GE HealthCare Technologies Prices as of Oct 29, 2026 Peers: Industry group
1 more company in this comparison (LNTH) Create a free account to keep reading and compare up to 10 companies.
PHG Koninklijke Philips Nv
$27.13 +9.5% 1M -1.7% 1Y
Market cap
$26.12B
P/E
14.0x
Revenue (TTM)
$20.60B
Div. yield
3.65%
Diagnostic Equipment Healthcare
6 wins
HUM Humana Inc
$417.46 +7.9% 1M +42.6% 1Y
Market cap
$50.13B
P/E
39.2x
Revenue (TTM)
$145.68B
Div. yield
0.64%
Managed Care Healthcare
5 wins

Head to Head

12 decided of 12

Koninklijke Philips leads on 6 of the 12 questions below (Koninklijke Philips 6, Humana 5, GE HealthCare Technologies 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionPHGHUMGEHCLeader
Larger companyMarket capitalisation $26.12B $50.13B $34.55B HUM
Cheaper on earningsLower P/E, profitable companies only 14.0x 39.2x 16.0x PHG
Cheaper on forward earningsLower price / next fiscal year consensus EPS 13.7x 48.3x 15.0x PHG
Faster revenue growthRevenue growth, trailing twelve months +6.1% +18.3% +6.9% HUM
More profitableNet margin, trailing twelve months 8.9% 0.9% 10.0% GEHC
Better return on capitalReturn on invested capital 11.5% 6.7% 10.8% PHG
Less leveragedLower net debt / EBITDA 1.8x -2.7x 2.0x HUM
Higher dividend yieldTrailing dividend yield 3.65% 0.64% 0.20% PHG
Better 1-year returnPrice return, last 12 months -1.7% +42.6% -1.2% HUM
Better 5-year returnAnnualised price return, 5 years -10.5%/yr -2.1%/yr — HUM
Less volatileAnnualised volatility, 1 year 28.3% 48.1% 35.4% PHG
Higher overall scoreMean of the five percentile scores vs peers 81/100 44/100 58/100 PHG

Percentile Scorecard

PHGHUMGEHC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisPHGHUMGEHC
Valuation 98 #6 of 227 58 #11 of 25 91 #22 of 227
Growth 96 #9 of 218 13 #21 of 24 36 #141 of 218
Profitability 96 #10 of 202 48 #13 of 24 79 #44 of 202
Financial Health 33 #156 of 233 68 #9 of 26 30 #164 of 233
Shareholder Returns 81 #26 of 130 33 #11 of 16 54 #60 of 130
Overall 81 44 58
  • PHG ranked among 247 companies in Medical Devices and Diagnostics
  • HUM ranked among 27 companies in Healthcare Payers and Distributors
  • GEHC ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodPHGHUMGEHCSPY
1 month +9.5%+7.9%+15.0% +0.7%
3 months +2.6%+13.8%+9.3% +3.7%
6 months +3.0%+76.6%+25.6% +7.1%
Year to date +0.2%+63.0%-6.8% +12.8%
1 year -1.7%+42.6%-1.2% +11.9%
3 years +45.8%-19.4%+21.0% +85.2%
3 years, per year +13.4%-6.9%+6.6% +22.8%
5 years -42.6%-9.9%— +67.6%
5 years, per year -10.5%-2.1%— +10.9%
10 years -10.1%+144.0%— +262.0%
10 years, per year -1.1%+9.3%— +13.7%

Risk

MeasurePHGHUMGEHCSPY
Volatility, 1Y 28.3%48.1%35.4% 12.7%
Downside volatility, 1Y 27.7%52.7%35.8% 12.6%
Beta vs S&P 500, 1Y 0.820.570.68 1.00
Return / volatility, 1Y -0.060.89-0.04 0.94
Max drawdown, 5Y -75.6%-70.9%-37.4% -25.4%
From 52-week high -17.6%-3.7%-13.3% -1.2%
52-week high $32.91$433.45$88.16 $779.14
52-week low $23.81$163.67$59.49 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultiplePHGHUMGEHC
P/E now vs peer median 14.0xmedian 28.7x 39.2xmedian 24.3x 16.0xmedian 28.7x
P/S now vs peer median 1.3xmedian 3.0x 0.3xmedian 0.3x 1.6xmedian 3.0x
EV/EBITDA now vs peer median 8.2xmedian 17.8x 11.7xmedian 12.9x 11.9xmedian 17.8x
P/FCF now vs peer median 6.0xmedian 26.4x 25.7xmedian 16.4x 18.3xmedian 26.4x
P/B now vs peer median 2.0xmedian 2.4x 2.6xmedian 2.5x 3.0xmedian 2.4x
PEG now vs peer median 0.33median 0.99 -1.46median 1.36 1.30median 0.99

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsPHGHUMGEHC
Revenue $20.60B $145.68B $21.64B
Gross profit $16.03B $19.89B $8.64B
Operating income $2.65B $2.71B $2.89B
Net income $1.39B $1.29B $2.21B
Free cash flow $4.34B $1.95B $1.89B
R&D $2.00B – $1.31B
EPS (diluted) $1.91 $10.56 $4.75
Cash & equivalents $2.04B $6.89B $2.86B
Total debt $9.51B $54.48B $9.97B
Shares (diluted) 962.50M 121.14M 453.00M
Enterprise value $15.27B -$37.67B $23.02B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricPHGHUMGEHC
P/E 14.0x 39.2x 16.0x
P/FCF 6.0x 25.7x 18.3x
P/Operating cash flow 9.8x 19.7x 14.3x
P/S 1.3x 0.3x 1.6x
P/B 2.0x 2.6x 3.0x
P/Tangible book 2.6x 2.6x 3.5x
EV/EBITDA 8.2x 11.7x 11.9x
EV/EBIT 12.6x 15.1x 14.4x
EV/Revenue 1.6x 0.3x 1.9x
EV/FCF 7.7x 21.0x 22.1x
EV/Operating cash flow 12.6x 16.1x 17.3x
PEG (3Y EPS CAGR) 0.33 -1.46 1.30

Growth

14 metrics
MetricPHGHUMGEHC
Revenue growth (1Y) 6.1% 18.3% 6.9%
Revenue CAGR (3Y) 2.3% 13.8% 3.9%
Gross profit growth (1Y) 82.4% 7.5% 4.6%
Gross profit CAGR (3Y) 6.7% 3.6% 3.9%
Operating income growth (1Y) 121.3% -17.9% 5.4%
Operating income CAGR (3Y) 52.0% -15.3% 4.6%
Net income growth (1Y) 293.5% -18.3% -3.5%
Net income CAGR (3Y) 35.6% -27.4% 7.6%
EPS growth (1Y) 539.4% -19.1% -2.0%
EPS CAGR (3Y) 42.2% -26.9% 12.3%
Operating cash flow growth (1Y) 116.7% -13.4% 30.5%
Operating cash flow CAGR (3Y) 53.6% -42.3% 4.5%
Free cash flow growth (1Y) 54.2% -20.1% 34.9%
Free cash flow CAGR (3Y) 45.6% -45.6% 2.7%

Profitability

14 metrics
MetricPHGHUMGEHC
Gross margin 77.8% 13.7% 39.9%
EBITDA margin 19.8% 2.4% 16.2%
Operating margin 12.9% 1.9% 13.3%
Pretax margin 11.9% 1.1% 12.8%
Net margin 8.9% 0.9% 10.0%
FCF margin 21.1% 1.3% 8.7%
Operating cash flow margin 12.9% 1.7% 11.2%
Return on equity 12.7% 6.8% 19.5%
Return on assets 5.4% 2.3% 5.8%
Return on invested capital 11.5% 6.7% 10.8%
Return on capital employed 11.8% 8.1% 10.0%
Asset turnover 0.7x 2.6x 0.6x
Cash conversion (OCF / net income) 1.9x 2.0x 1.1x
Stock comp / revenue 0.7% 0.2% 0.7%

Financial Health

11 metrics
MetricPHGHUMGEHC
Debt / assets 31.2% 25.5% 26.0%
Debt / equity 0.7x 0.8x 0.9x
Net debt / EBITDA 1.8x -2.7x 2.0x
Debt / FCF 2.2x 7.5x 5.3x
Liabilities / assets 57.1% 66.3% 69.7%
Equity / assets 42.9% 33.7% 30.3%
Interest coverage 6.2x 3.8x 6.6x
Current ratio 1.3x 1.7x 1.3x
Quick ratio 0.7x 1.3x 0.9x
Cash ratio 0.2x 1.0x 0.3x
Altman Z-score – 4.61 1.92

Shareholder Returns

7 metrics
MetricPHGHUMGEHC
Dividend yield 3.6% 0.6% 0.2%
Net buyback yield -0.5% 0.3% 0.8%
Shareholder yield 3.2% 0.9% 1.0%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusPHGHUMGEHC
Forward P/E 13.7xFY2026 48.3xFY2026 15.0xFY2026
EPS, next fiscal year $1.98FY2026 $8.65FY2026 $5.09FY2026
EPS growth, next FY +6.5%FY2026 -49.5%FY2026 +10.9%FY2026
EPS growth, the year after -10.1% +84.9% -0.4%
Revenue, next fiscal year $21.63BFY2026 $166.70BFY2026 $22.47BFY2026
Revenue growth, next FY +1.8%FY2026 +28.6%FY2026 +8.9%FY2026
Revenue growth, the year after -8.2% +7.6% +7.5%
PHG estimates →HUM estimates →GEHC estimates →

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersPHGHUMGEHC
Held by institutions 5.4% 98.6% 87.0%
Institutions holding 364 928 1,222
Change in shares held, QoQ +0.8% +2.7% +1.7%
Institutions buying 267 559 539
Institutions selling 76 266 461
Buyers to sellers 3.51 2.10 1.17
PHG holders →HUM holders →GEHC holders →

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

PHGHUMGEHC
PHG 1.00 0.03 0.55
HUM 0.03 1.00 0.07
GEHC 0.55 0.07 1.00

Add a Peer

Largest companies in the same industry
PHG · Diagnostic Equipment
+LNTHLantheus Holdings +HTFLHeartflow +NEOGNeogen +BFLYButterfly Network +CBLLCeribell +QDELQuidelOrtho +VREXVarex Imaging +NNNNAnbio Biotechnology
Plot all 112 Diagnostic Equipment stocks → Plot all 25 Managed Care stocks →

Related Comparisons

PHG vs LNTHLantheus Holdings PHG vs HTFLHeartflow PHG vs NEOGNeogen PHG vs BFLYButterfly Network

Frequently Asked Questions

Which is bigger, PHG, HUM and GEHC?

Humana (HUM) is the largest by market capitalisation: Koninklijke Philips (PHG) $26.12B, Humana (HUM) $50.13B, GE HealthCare Technologies (GEHC) $34.55B.

Which stock is cheaper, PHG, HUM and GEHC?

Koninklijke Philips (PHG) trades on the lowest price-to-earnings ratio (Koninklijke Philips (PHG) 14.0x, Humana (HUM) 39.2x, GE HealthCare Technologies (GEHC) 16.0x). On next year's consensus earnings, Koninklijke Philips (PHG) is cheapest (Koninklijke Philips (PHG) 13.7x, Humana (HUM) 48.3x, GE HealthCare Technologies (GEHC) 15.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Humana (HUM) grew revenue fastest over the trailing twelve months: Koninklijke Philips (PHG) +6.1%, Humana (HUM) +18.3%, GE HealthCare Technologies (GEHC) +6.9%.

Which company is more profitable?

GE HealthCare Technologies (GEHC) has the highest net margin (Koninklijke Philips (PHG) 8.9%, Humana (HUM) 0.9%, GE HealthCare Technologies (GEHC) 10.0%). On return on invested capital, Koninklijke Philips (PHG) leads (Koninklijke Philips (PHG) 11.5%, Humana (HUM) 6.7%, GE HealthCare Technologies (GEHC) 10.8%).

Which stock has performed better?

Over the past year Humana (HUM) returned the most: Koninklijke Philips (PHG) -1.7%, Humana (HUM) +42.6%, GE HealthCare Technologies (GEHC) -1.2%. Over five years, Humana (HUM) compounded fastest (Koninklijke Philips (PHG) -10.5%/yr, Humana (HUM) -2.1%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Koninklijke Philips (PHG) has the highest dividend yield: Koninklijke Philips (PHG) 3.65%, Humana (HUM) 0.64%, GE HealthCare Technologies (GEHC) 0.20%.

Which stock is riskier?

By one-year price volatility, Koninklijke Philips (PHG) has been the steadiest (Koninklijke Philips (PHG) 28.3%, Humana (HUM) 48.1%, GE HealthCare Technologies (GEHC) 35.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, PHG, HUM and GEHC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Koninklijke Philips (PHG) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.